Allarity Therapeutics (ALLR) Long-Term Investments (2020 - 2022)

Allarity Therapeutics (ALLR) has 3 years of Long-Term Investments data on file, last reported at $254000.0 in Q2 2022.

• Quarterly Long-Term Investments changed N/A year-over-year to $254000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $254000.0 (changed N/A YoY) and the FY2021 annual result came in at $350000.0, down 58.58% from the prior year.
• Long-Term Investments eased to $254000.0 in Q2 2022, from $314000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $845000.0 in Q4 2020 to a low of $254000.0 in Q2 2022.
• A 3-year average of $450800.0 and a median of $350000.0 in 2021 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 58.58% in 2021, down 58.58% in 2021.
• Tracing ALLR's Long-Term Investments over 3 years: stood at $845000.0 in 2020, then slumped by 58.58% to $350000.0 in 2021, then dropped by 27.43% to $254000.0 in 2022.
• The last three Long-Term Investments figures came in at $254000.0 (Q2 2022), $314000.0 (Q1 2022), and $350000.0 (Q4 2021), per Business Quant data.